GGrantIndex
Sort

39,280 grants matching leukemia

The function and underlying mechanism of TET1 in myelodysplastic syndromes

$559,500
Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2021 · DK

Inflammation, Macrophage Differentiation, and Cancer

$559,389
Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Childhood Leukemia: Oxidative Stress, Cognitive Changes & Academic Outcomes

$559,353
Ida Marie Moore · University Of Arizona · R01 · FY2009 · NR

Investigation into Arterial Stiffness and Hypertension

$559,327
Zhongjie Sun · University Of Tennessee Health Sci Ctr · R01 · FY2021 · HL

Investigation into Arterial Stiffness and Hypertension

$559,327
Zhongjie Sun · University Of Tennessee Health Sci Ctr · R01 · FY2023 · HL

Investigation into Arterial Stiffness and Hypertension

$559,327
Zhongjie Sun · University Of Tennessee Health Sci Ctr · R01 · FY2020 · HL

Clinical Trial of Ceramide nanoLiposomes in AML

$559,269
Charles E Chalfant · University Of Virginia · P01 · FY2023 · CA

Clinical Trial of Ceramide nanoLiposomes in AML

$559,269
Charles E Chalfant · University Of Virginia · P01 · FY2022 · CA

System dynamics and gene network architecture of early T-cell development

$559,065
Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2019 · HD

Murine Model for HIV-1 Replication

$559,001
Salk Institute For Biological Studies · R01 · FY2004 · DA

Targeting FTO to treat acute myeloid leukemia

$558,898
Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA

Regulation of the intestinal stem cell compartment after hematopoietic transplantation

$558,680
Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2016 · HL

Regulation of the intestinal stem cell compartment after hematopoietic transplantation

$558,680
Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2015 · HL

Targeting FTO to treat acute myeloid leukemia

$558,632
Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

Role of H2AX and ATM in Suppression of Thymic Lymphomas

$558,569
Frederick W Alt · Dana-Farber Cancer Inst · P01 · FY2008 · CA

RETROVIRUS EVOLUTION

$558,530
Tufts University Boston · R01 · FY2001 · CA

Genetics-guided Individualization of Thiopurine Therapy

$558,496
Jun J. Yang · St. Jude Children'S Research Hospital · R01 · FY2018 · GM

GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA

$558,420
Nicola J Camp · University Of Utah · R01 · FY2012 · CA

Molecular Genetics

$558,342
Carlo M Croce · University Of California, San Diego · P01 · FY2012 · CA

GP130/STAT3 signalling in articular cartilage development and regeneration

$558,322
Denis Evseenko · University Of Southern California · R01 · FY2018 · AR

Blockade of IL-23 for the Prevention of Graft Versus Host Disease

$558,195
William R. Drobyski · Medical College Of Wisconsin · R01 · FY2021 · HL

Blockade of IL-23 for the Prevention of Graft Versus Host Disease

$558,195
William R. Drobyski · Medical College Of Wisconsin · R01 · FY2022 · HL

LY-1 B Cells: Developmental Origins and V Gene Biases

$558,031
Richard R Hardy · Research Inst Of Fox Chase Can Ctr · R01 · FY2008 · AI

Development of Novel AIDS Gene Therapy Strategies in the Macaque SHIV Model

$557,902
Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2009 · AI

Project 1: Promoting Graft-versus-Tumor Effects in the Bone Marrow

$557,823
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2022 · CA